AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
4.150
+0.330 (8.64%)
At close: Apr 30, 2026, 4:00 PM EDT
4.130
-0.020 (-0.48%)
After-hours: Apr 30, 2026, 6:27 PM EDT
AbCellera Biologics Employees
AbCellera Biologics had 562 employees as of December 31, 2025. The number of employees decreased by 34 or -5.70% compared to the previous year.
Employees
562
Change (1Y)
-34
Growth (1Y)
-5.70%
Revenue / Employee
$133,680
Profits / Employee
-$260,520
Market Cap
1.26B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 562 | -34 | -5.70% |
| Dec 31, 2024 | 596 | 10 | 1.71% |
| Dec 31, 2023 | 586 | 91 | 18.38% |
| Sep 30, 2023 | 630 | 155 | 32.63% |
| Jun 30, 2023 | 590 | 140 | 31.11% |
| Mar 31, 2023 | 525 | 125 | 31.25% |
| Dec 31, 2022 | 495 | 109 | 28.24% |
| Sep 30, 2022 | 475 | 115 | 31.94% |
| Jun 30, 2022 | 450 | 148 | 49.01% |
| Mar 31, 2022 | 400 | 194 | 94.17% |
| Dec 31, 2021 | 386 | 180 | 87.38% |
| Sep 30, 2021 | 360 | 186 | 106.90% |
| Jun 30, 2021 | 302 | 128 | 73.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| UroGen Pharma | 291 |
| MapLight Therapeutics | 133 |
| Olema Pharmaceuticals | 131 |
| MoonLake Immunotherapeutics | 130 |
| DBV Technologies | 117 |
| ArriVent BioPharma | 77 |
| GH Research | 73 |
ABCL News
- 9 days ago - AbCellera Biologics Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference - Transcripts
- 10 days ago - AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call - Business Wire
- 4 weeks ago - AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026 - Business Wire
- 6 weeks ago - AbCellera Biologics Transcript: 2026 KeyBanc Capital Markets Healthcare Forum - Transcripts
- 2 months ago - AbCellera Biologics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - AbCellera Biologics Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - AbCellera Reports Full Year 2025 Business Results - Business Wire
- 2 months ago - AbCellera to Present at Upcoming Investor Conferences in March and April 2026 - Business Wire